Assessment of the effect of calcium on the anti-inflammatory activity of etoricoxib in albino rats

Sonali Naringrekar, Jayesh Mamtora
{"title":"Assessment of the effect of calcium on the anti-inflammatory activity of etoricoxib in albino rats","authors":"Sonali Naringrekar, Jayesh Mamtora","doi":"10.18203/2319-2003.IJBCP20212078","DOIUrl":null,"url":null,"abstract":"Background: It would be worthwhile to investigate if it is possible to obtain an anti-inflammatory effect with a lower dose of etoricoxib after it has been combined with calcium, the effect of which is equivalent to higher dose of etoricoxib. Hence the aim was to study effect of calcium and calcium gluconate on the anti-inflammatory activity of etoricoxib. Methods: Animals were distributed in five groups each group containing six rats. Experiments were conducted between 9:00 to 16:00 hours. All animal procedures were performed in accordance with the recommendations for proper care and use of laboratory animal .The doses of drugs employed in the study were based upon the human dose after conversion to that of rat. Results: The results of present study indicate that calcium gluconate (50 mg/kg) combined with etoricoxib (5 mg/kg) possesses significant anti-inflammatory property both in acute and subacute models of inflammation which was comparable to that of etoricoxib (8 mg/kg). Conclusions: From the present study it is concluded that calcium gluconate (50 mg/kg) possesses an antiinflammatory activity. Lower dose of etoricoxib (5 mg/kg) if combined with calcium gluconate (50 mg/kg) can produce significant anti-inflammatory effect. The advantages of such combined preparations are obviously a reduction in the dose of etoricoxib that could still produce significant anti-inflammatory action and a possible protection against COX -2 inhibitor induced prothrombotic events. It is worthwhile to evaluate such preparations through clinical trials.","PeriodicalId":13898,"journal":{"name":"International journal of basic and clinical pharmacology","volume":"457 1","pages":"683"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of basic and clinical pharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18203/2319-2003.IJBCP20212078","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: It would be worthwhile to investigate if it is possible to obtain an anti-inflammatory effect with a lower dose of etoricoxib after it has been combined with calcium, the effect of which is equivalent to higher dose of etoricoxib. Hence the aim was to study effect of calcium and calcium gluconate on the anti-inflammatory activity of etoricoxib. Methods: Animals were distributed in five groups each group containing six rats. Experiments were conducted between 9:00 to 16:00 hours. All animal procedures were performed in accordance with the recommendations for proper care and use of laboratory animal .The doses of drugs employed in the study were based upon the human dose after conversion to that of rat. Results: The results of present study indicate that calcium gluconate (50 mg/kg) combined with etoricoxib (5 mg/kg) possesses significant anti-inflammatory property both in acute and subacute models of inflammation which was comparable to that of etoricoxib (8 mg/kg). Conclusions: From the present study it is concluded that calcium gluconate (50 mg/kg) possesses an antiinflammatory activity. Lower dose of etoricoxib (5 mg/kg) if combined with calcium gluconate (50 mg/kg) can produce significant anti-inflammatory effect. The advantages of such combined preparations are obviously a reduction in the dose of etoricoxib that could still produce significant anti-inflammatory action and a possible protection against COX -2 inhibitor induced prothrombotic events. It is worthwhile to evaluate such preparations through clinical trials.
钙对白化病大鼠依托昔布抗炎活性的影响
背景:低剂量依托瑞昔布与钙联用后是否有可能获得与高剂量依托瑞昔布相当的抗炎作用,值得研究。目的是研究钙和葡萄糖酸钙对依托昔布抗炎活性的影响。方法:随机分为5组,每组6只。实验时间为9:00 - 16:00。所有动物实验程序均按照实验动物的适当护理和使用建议进行,研究中使用的药物剂量以人给药剂量换算成大鼠给药剂量为基础。结果:本研究结果表明,葡萄糖酸钙(50 mg/kg)联合依托昔布(5 mg/kg)在急性和亚急性炎症模型中均具有显著的抗炎作用,与依托昔布(8 mg/kg)相当。结论:葡萄糖酸钙(50 mg/kg)具有抗炎活性。低剂量依托昔布(5mg /kg)与葡萄糖酸钙(50mg /kg)合用可产生显著的抗炎作用。这种联合制剂的优点是明显减少了依托昔布的剂量,但仍能产生显著的抗炎作用,并可能对COX -2抑制剂诱导的血栓前事件有保护作用。通过临床试验对这些制剂进行评价是值得的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信